Sigyn Therapeutics, Inc. (OTCMKTS:SIGY – Get Free Report)’s share price traded up 22.2% during trading on Thursday . The stock traded as high as $6.00 and last traded at $5.50. 519 shares changed hands during mid-day trading, an increase of 76% from the average session volume of 295 shares. The stock had previously closed at $4.50.
Sigyn Therapeutics Stock Performance
The company has a 50 day moving average of $4.03 and a 200 day moving average of $1.52. The stock has a market capitalization of $6.71 million, a price-to-earnings ratio of -1.53 and a beta of -1.65.
About Sigyn Therapeutics
Sigyn Therapeutics, Inc operates as a medical technology company, focuses on creating therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, the cause of hospital deaths.
See Also
- Five stocks we like better than Sigyn Therapeutics
- Trading Halts Explained
- 3 Value Stocks Too Small For Buffett’s Portfolio
- 3 Best Fintech Stocks for a Portfolio Boost
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- Airline Stocks – Top Airline Stocks to Buy Now
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Sigyn Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sigyn Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
